Efficacy and Mechanisms of the Dual-Drug Approach Using TGP and Colchicine

Overview

This study investigates the efficacy and mechanisms of a dual-drug regimen combining Total Glucosides of Paeony (TGP) and colchicine for treating Behçet’s disease (BD).

Background

Behçet’s disease is a complex inflammatory condition characterized by recurrent oral and genital ulcers, significantly impacting patients' quality of life. Colchicine is a first-line treatment for BD's mucocutaneous manifestations, while the combined use of TGP has been a longstanding practice in China. Understanding the efficacy and mechanisms of this dual approach is crucial for optimizing treatment strategies.

Data Highlights

Key Findings

• The combination of TGP and colchicine showed superior efficacy in reducing oral and genital ulcers compared to monotherapy.
• Core targets identified include MMP9, ICAM1, FGF2, TLR4, EGFR, and NOS3, which are involved in inflammation and immune response.
• Molecular docking revealed high affinity interactions between colchicine and key targets such as EGFR and ICAM1.
• Both treatment groups achieved complete ulcer resolution by M3, indicating long-term efficacy.
• Transient diarrhea was noted in the combination group, but no drug-associated cytopenia was reported.

Clinical Implications

Clinicians should consider this combination therapy.

Conclusion

The study highlights the role of TGP in combination with colchicine in treating Behçet’s disease.

Related Resources & Content

1. Authors, Source, Year -- Efficacy and Mechanisms of the Dual-Drug Approach Using TGP and Colchicine
2. Frontiers in Medicine — A comparative study on the clinical differences in traditional Chinese medicine pattern in ulcerative colitis utilizing multidimensional data
3. Clinical Rheumatology — A Comprehensive Review and Meta-Analysis on the Efficacy and Safety of Total Glucosides of Peony in Combination with Methotrexate for Treating Rheumatoid Arthritis
4. European Journal of Preventive Cardiology — Evaluating the Role of Basal Inflammation in Colchicine Treatment for Patients with Stable Coronary Artery Disease
5. Frontiers in Medicine — Clinical and immunomicrobiome correlates of a standardized Qingpao Chushi Jiedu Fang regimen in palmoplantar pustulosis
6. EULAR recommendations for the management of Behçet’s syndrome: 2025 update
7. A Comprehensive Review and Meta-Analysis on the Efficacy and Safety of Total Glucosides of Peony in Combination with Methotrexate for Treating Rheumatoid Arthritis
8. https://academic.oup.com/bjd/article/194/1/e1/8268116
9. Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome - PubMed
10. Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome | New England Journal of Medicine
11. Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial - PubMed
12. Efficacy and safety of low-dose interleukin 2 for Behçet’s syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial
13. 2018 update of the EULAR recommendations for the management of Behçet's syndrome - PubMed
14. Frontiers | Efficacy and safety of total glucosides of paeony in the treatment of recurrent aphthous ulcers: a systematic review and meta-analysis